跳至主要内容
临床试验/NCT05497232
NCT05497232Unknown不适用

Clinical Analysis of Simultaneous Pancreas-kidney Transplantation for End-stage Renal Disease Associated With Diabetes Mellitus

Second Affiliated Hospital of Guangzhou Medical University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2022年9月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
200
试验地点
1
主要终点
Patient survival & pancreas graft survival & renal graft survival

研究概览

简要总结

The first pancreas transplantation was performed in 1966, by 2015, more than 40,000 pancreas transplantation have been performed worldwide. Nevertheless, only several Chinese organ transplant centers carry out SPK because of surgery complications. simultaneous pancreas-kidney transplantation is a new and promising therapeutic option for the treatment for type 1 diabetes mellitus patients and end-stage renal disease. the preliminary treatment results are summarized to promote the further development of this work in China.

详细描述

simultaneous pancreas-kidney transplantation using the surgical technique was performed in our department from September 2016 to January 2023 in the Department of Transplantation of the Second Affiliated Hospital of Guangzhou Medical University. Patients were followed up for 2 to 36 months to summarize the efficacy and complications. we examined the influence of SPK on patient and graft survivals.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of Diabetes patients with end-stage renal disease;
  • First time receiving SPKT;

排除标准

  • Pulmonary infection, urinary tract infection, hematuria CMV or BK virus infection occurred during treatment;
  • Using a large number of abnormal biological products (blood transfusion, plasma or coagulation factors) may contain foreign DNA;
  • Loss of graft due to thrombosis or AR;
  • Patients who are pregnant or have malignant tumors or patients with a history of cell therapy, whose tumor signals interfere with dd-cfDNA detection;
  • Patients who have poor compliance during treatment or suffer from mental illness.

结局指标

主要结局

Patient survival & pancreas graft survival & renal graft survival

时间窗: 12 months

Renal graft survival was defined as the exclusion of graft resection, restoration of dialysis, and death with graft function. Survival of the transplanted pancreas excluded resection of the transplanted pancreas, recovery of preoperative insulin dosage and death with graft function.

次要结局

未报告次要终点

研究者

发起方
Second Affiliated Hospital of Guangzhou Medical University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验